AbbVie Inc. (ABBV)

AbbVie Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 16, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	504,371	403,830	314,021	273,605	285,707	239,371
Market Cap Growth	26.21%	28.60%	14.77%	-4.24%	19.36%	26.54%
Enterprise Value	568,687	467,051	378,098	321,532	343,858	307,886
Last Close Price	285.42	221.85	166.71	140.26	140.59	113.37

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 16, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	80.63	96.47	74.10	56.77	24.25	20.87
Forward PE	18.95	16.57	14.81	13.96	12.72	10.04
PS Ratio	7.83	6.60	5.57	5.04	4.92	4.26
PB Ratio	-	-125.10	93.35	26.32	16.53	15.51
P/FCF Ratio	27.70	22.67	17.61	12.40	11.78	10.89
P/OCF Ratio	25.86	21.22	16.70	11.98	11.45	10.51
PEG Ratio	1.41	1.09	1.68	58.43	93.44	2.03

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 16, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
EV/Sales Ratio	8.83	7.64	6.71	5.92	5.92	5.48
EV/EBITDA Ratio	18.49	15.97	14.65	11.95	11.98	10.89
EV/EBIT Ratio	24.84	22.12	21.70	17.65	17.00	15.58
EV/FCF Ratio	31.23	26.22	21.20	14.57	14.18	14.00

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 16, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Debt / Equity Ratio	-12.04	-21.19	20.29	5.83	3.74	5.03
Debt / EBITDA Ratio	2.28	2.31	2.61	2.23	2.22	2.71
Debt / FCF Ratio	3.89	3.84	3.83	2.75	2.66	3.53
Net Debt / Equity Ratio	-10.92	-19.56	18.64	4.59	3.20	4.39
Net Debt / EBITDA Ratio	2.09	2.16	2.43	1.78	1.93	2.40
Net Debt / FCF Ratio	3.53	3.54	3.52	2.17	2.28	3.08
Asset Turnover	0.47	0.46	0.42	0.40	0.41	0.38
Inventory Turnover	3.47	3.80	4.03	4.38	4.93	5.38
Quick Ratio	0.49	0.41	0.43	0.63	0.69	0.56
Current Ratio	0.81	0.67	0.66	0.87	0.96	0.79
Return on Equity (ROE)	-	6225.00%	62.29%	35.20%	72.40%	80.95%
Return on Assets (ROA)	10.51%	9.81%	8.07%	8.32%	8.86%	8.31%
Return on Invested Capital (ROIC)	17.70%	17.29%	28.05%	21.71%	22.82%	20.09%
Return on Capital Employed (ROCE)	24.50%	23.30%	18.10%	18.80%	18.50%	17.70%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 16, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Earnings Yield	1.24%	1.05%	1.36%	1.78%	4.14%	4.82%
FCF Yield	3.61%	4.41%	5.68%	8.06%	8.49%	9.19%
Dividend Yield	2.42%	2.91%	3.54%	3.87%	3.54%	3.92%
Payout Ratio	195.50%	275.84%	257.71%	216.72%	84.85%	80.24%
Buyback Yield / Dilution	-0.03%	-	-0.06%	0.28%	-0.06%	-6.22%
Total Shareholder Return	2.40%	2.91%	3.48%	4.15%	3.48%	-2.29%

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Aug 3, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 16, 2026

Data Sources Report a data error